CME Group Bhd (XKLS:7018) Research & Development: RM0.00 Mil (TTM As of Mar. 2026)


What is CME Group Bhd Research & Development?

CME Group Bhd XKLS:7018 -50.00% Research & Development is RM0.00 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CME Group Bhd's Research & Development for the three months ended in Mar. 2026 was RM0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.00 Mil.

CME Group Bhd  (XKLS:7018) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CME Group Bhd Research & Development Related Terms

CME Group Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for CME Group Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group Bhd Research & Development Chart

CME Group Bhd Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Jun19 Jun20 Jun21 Jun22 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CME Group Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CME Group Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.00 Mil mean?
CME Group Bhd (XKLS:7018) has a Research & Development of RM0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on CME Group Bhd and its competitors.
Is CME Group Bhd's Research & Development too high?
CME Group Bhd's current Research & Development is RM0.00 Mil.
How does CME Group Bhd's Research & Development compare to TSLA and GM?
CME Group Bhd's Research & Development of RM0.00 Mil can be compared against companies in the Vehicles & Parts industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Vehicles & Parts company?
A good Research & Development depends on the Vehicles & Parts industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CME Group Bhd and its competitors. CME Group Bhd's current Research & Development is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group Bhd stock overvalued right now?
Based on GuruFocus' analysis, CME Group Bhd (XKLS:7018) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.03, compared to a current price of RM0.01 — trading 83.3% below its estimated fair value. The current Research & Development is RM0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CME Group Bhd (XKLS:7018), the current Research & Development is RM0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CME Group Bhd Business Description

Address Lot 19, Jalan Delima 1/1, Taman Perindustrian Teknologi Tinggi Subang, Subang Jaya, SGR, MYS, 47500
CME Group Bhd is a Malaysia-based investment holding company. The company's operating segment includes Investment holding; Manufacturing; Trading and Others. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the designing, manufacturing, sales, and servicing of fire fighting and specialist vehicles. Geographically, it operates only in Malaysia.